Theramex Ireland Limited
6 products tracked · names used in filings: Theramex Ireland Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 08 Jan 2026🇪🇺 EU approval (EC decision)
Osqay (denosumab) approved in the EU
Marketing authorisation to Theramex Ireland Limited; Biosimilar, Additional monitoring · source
Thu 13 Nov 2025🇪🇺 CHMP positive opinion
Osqay (denosumab): CHMP positive opinion
Theramex Ireland Limited; Biosimilar, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Osqay denosumab | Authorised | 2026-01-08 |
| 🇪🇺 | Eladynos abaloparatide | Authorised | 2022-12-12 |
| 🇪🇺 | Yselty linzagolix choline | Authorised | 2022-06-14 |
| 🇪🇺 | Livogiva teriparatide | Authorised | 2020-08-27 |
| 🇪🇺 | Ovaleap follitropin alfa | Authorised | 2013-09-27 |
| 🇪🇺 | Zoely nomegestrol;estradiol | Authorised | 2011-07-26 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.